Matthew McCord

2 months ago | onlinelibrary.wiley.com | Robert Dreicer |Michael Devitt |Matthew McCord |Prem P. Batchala

1 Introduction In the United States, prostate cancer is the most common non-cutaneous malignancy in males [1]. Distant metastasis is present in 4%–25% of prostate cancer patients [2], but intracranial metastases are rare (0.6%–2.9%) and involve the meninges (66%) more commonly than the parenchyma (33%) [3]. Advanced prostate cancer (aPC) with small cell and neuroendocrine-transformed types are more frequently associated with intraparenchymal brain metastases (BMETS) [4].

Jul 5, 2024 | thejns.org | Vineeth Thirunavu |Michael Drumm |Matthew McCord |Alicia Steffens

Share Link Copy this link, or click below to email it to a friend Email this content or copy the link directly: The link was not copied. Your current browser may not support copying via this button.